SABRA BECKER: Open Payments
NPI 1326204124 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 53 payments from 11 companies in 2025. Trend: 2023 $566 · 2024 $498 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $392 |
| Lundbeck LLC | 3 | $83 |
| Merz Pharmaceuticals, LLC | 1 | $47 |
| GE HEALTHCARE | 1 | $38 |
| Averitas Pharma Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Tanabe Pharma America, Inc. | 1 | $18 |
Products named: QULIPTA, UBRELVY, BOTOX, VYEPTI, Xeomin, QUTENZA, REXULTI, Symbravo.
Industry payments across CT — which companies pay providers there.
